Bio-Techne (NASDAQ: TECH) — Company Overview, News & Financial Data
Bio-Techne develops and sells biotechnology products for research and diagnostics, focusing on advancing scientific discovery globally.
Bio-Techne
Bio-Techne is a life sciences company that develops, manufactures, and sells biological reagents, instrument systems, and clinical diagnostic products for the research and clinical diagnostic markets. Its offerings include recombinant proteins, antibodies, immunoassays, spatial biology tools, enzymes, cell culture media, microfluidic instruments, and molecular diagnostic controls. The company serves biotechnology firms, pharmaceutical companies, academic research institutions, and clinical laboratories globally. Bio-Techne operates through dedicated brands including R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics, supporting applications in drug discovery, biomarker detection, cell therapy, and translational medicine.
Snapshot
Operations
Products and/or services of Bio-Techne
- Recombinant Proteins and Antibodies: Production and distribution of bioactive proteins, monoclonal and polyclonal antibodies, enzymes, and small molecules for life science research, cell culture, targeted protein degradation, and cell and gene therapy manufacturing.
- Immunoassays and ELISA Solutions: Development of enzyme-linked immunosorbent assay kits, Simple Plex automated immunoassays, Luminex multiplex assays, and antibody arrays utilized in academic and pharmaceutical laboratories for precise biomarker quantification and disease research.
- Automated Protein Analysis Systems: Provision of analytical instrument platforms including Simple Western, Maurice, Ella, and micro-flow imaging systems, enabling automated capillary electrophoresis, immunoassay execution, and microparticle analysis for biotherapeutic development and quality control.
- Spatial Biology Platforms and Assays: Supply of RNAscope in situ hybridization probes, COMET spatial biology instrumentation, and tissue-based assay panels designed for targeted RNA and multiplexed protein detection across oncology and neuroscience research applications.
- Clinical Diagnostic Quality Controls: Manufacturing of blood gas, hematology, CO-oximetry, and molecular diagnostic controls, along with contract development and manufacturing services provided to diagnostic equipment manufacturers and clinical testing laboratories.
- Molecular Diagnostic Testing Kits: Provision of specialized molecular diagnostic assay kits, including Amplidex genetic testing and Quantidex oncology testing panels, designed for clinical laboratories evaluating genetic mutations and cancer biomarkers.
Bio-Techne executive team
- Kim KeldermanCEO, President & Director
- James T. HippelExecutive VP of Finance & CFO
- Shane V. BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer
- William A. GeistPresident of Protein Sciences Segment
- Gary J. LathamVP & CTO
- David ClairVice President of Investor Relations
- Martin WirtzSenior Vice President of Strategy & Corporate Development
- Cheryl BethuneSenior VP & Chief Human Resources Officer
- Luca CicchettiManaging Director
- Steven C. CrousePresident of Diagnostics & Spatial Biology Segment